Pharmacists in Kewaunee, WI Accepting Medicare

3 Pharmacists found. Showing 1 - 3

Ms. Sarah Ellen Bartel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 931 Marquette Dr, Kewaunee, WI 54216 Phone: 920-388-2227    Fax: 920-388-3383

Mr. Thomas James Rydzewski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 802 N Main St, Kewaunee, WI 54216 Phone: 920-388-2231    Fax: 920-388-2459

Sarah Anne Nash, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 802 N Main St, Kewaunee, WI 54216 Phone: 920-388-2915

News Archive

Chocolates inhibit enzyme known to raise blood pressure

Numerous studies have shown that cocoa has a protective effect against cardiovascular diseases. The reason for this has now been uncovered by researchers at Linköping University in Sweden. When a group of volunteers devoured a good-sized piece of dark chocolate, it inhibited an enzyme in their bodies that is known to raise blood pressure.

Depression among patients with coronary artery disease

Depression has long had a popular link to cardiovascular disease and death. However, only during the last 15 years scientific evidence supporting this common wisdom has been available (Glassman et al., 2007a).

Social and economic burden of insomnia is high

A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment.

Governments should increase efforts to reduce stigma, improve access to HIV services among MSM, UNAIDS Executive Director Sidibe says

Governments worldwide should take action to eliminate stigma and discrimination against men who have sex with men, women who have sex with women and transgender people and improve their access to HIV services, UNAIDS Executive Director Michel Sidibe said recently, the Stabroek News reports.

Large trial on low-dose aspirin in diabetics

Type 2 diabetics treated with low-dose aspirin did not have a significantly lower incidence of atherosclerotic events than those who received placebo in this primary prevention trial of low-dose aspirin, according to research presented at the American Heart Association's Scientific Sessions 2008. However, sub-group analyses showed a significant reduction with aspirin in both atherosclerotic events in those over 65 years of age, and a reduction in cerebrocardiovascular deaths.

Read more Medical News

› Verified 2 days ago